Pre-clinical Cushing's syndrome: An unexpected frequent cause of poor glycaemic control in obese diabetic patients

被引:135
作者
Leibowitz, G
Tsur, A
Chayen, SD
Salameh, M
Raz, I
Cerasi, E
Gross, DJ
机构
[1] HADASSAH UNIV HOSP, DEPT ENDOCRINOL & METAB, IL-91120 JERUSALEM, ISRAEL
[2] HEBREW UNIV JERUSALEM, DEPT MED, HADASSAH MED CTR, JERUSALEM, ISRAEL
关键词
D O I
10.1046/j.1365-2265.1996.737558.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Autonomous cortisol secretion without clinical stigmata of Cushing's syndrome (CS) has been recently recognized and termed pre-clinical or subclinical GS. The common assumption is that GS is an extremely rare cause of uncontrolled diabetes; however, the prevalence of this entity has not been studied. We assessed the prevalence of pre-clinical GS among obese patients with uncontrolled diabetes. PATIENTS AND DESIGN (1) In a retrospective analysis, the medical records of 63 patients with endogenous GS were reviewed. (2) In a cross-sectional study, 90 obese patients (BMI >25 kg/m(2)) followed in a University Hospital and the local Health Fund endocrine and diabetes clinics, with poorly controlled diabetes (glycosylated haemoglobin >9%), underwent an overnight 1 mg dexamethasone suppression. In patients with non-suppressible cortisol levels (>140 nmol/l), Liddle's 2 and 8 mg dexamethasone suppression tests and imaging studies were performed. MEASUREMENTS The prevalence of poorly controlled diabetes, the major presenting symptom of CS, was assessed in the retrospective analysis. The prevalence of 'true' GS and the false positive rate in the overnight dexamethasone suppression test were calculated. The endocrine evaluation of the patients with pre-clinical GS and the effects of surgical cure on glycaemic control are described. RESULTS In the retrospective analysis, 11 (17.5%) had diabetes and 2 (3.2%) lacked the classic physical characteristics of the syndrome. In the cross-sectional study, 4 patients failed to suppress plasma cortisol (<140 nmol/l). In one patient the diagnosis of GS was not confirmed by a standard Liddle's test and was therefore considered false positive. In the other 3, the diagnosis of GS was confirmed (prevalence of 3.3%, 95% confidence interval 1-9%). In all other patients the overnight cortisol suppression test was normal (cortisol level 47.3 +/- 2.5 nmol/l (mean +/- SEM)). After surgical treatment of GS, glycaemic control was markedly improved in all 5 patients (2 from retrospective and 3 from cross-sectional studies). CONCLUSIONS The prevalence of pre-clinical Cushing's syndrome in obese patients with poorly controlled diabetes appears to be considerably higher than previously believed. The overnight dexamethasone suppression test proved to be a simple, sensitive and highly specific screening test for Cushing's syndrome despite the presence of obesity and hyperglycaemia.
引用
收藏
页码:717 / 722
页数:6
相关论文
共 27 条
[1]  
American Diabetes Association, 1993, DIAB 1993 VIT STAT
[2]  
Boyle PJ, 1993, DIABETES REV, V1, P301
[3]   CUSHINGS-SYNDROME - REVIEW OF DIAGNOSTIC-TESTS [J].
CRAPO, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (09) :955-977
[4]   THE OVERNIGHT DEXAMETHASONE TEST IS A WORTHWHILE SCREENING-PROCEDURE [J].
CRONIN, C ;
IGOE, D ;
DUFFY, MJ ;
CUNNINGHAM, SK ;
MCKENNA, TJ .
CLINICAL ENDOCRINOLOGY, 1990, 33 (01) :27-33
[5]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137
[6]   CUSHINGS SYNDROME - PROSPECTIVE STUDY OF DIAGNOSTIC METHODS [J].
EDDY, RL ;
JONES, AL ;
GILLILAND, PF ;
IBARRA, JD ;
THOMPSON, JQ ;
MCMURRY, JF .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (05) :621-630
[7]  
Exton J H, 1970, Recent Prog Horm Res, V26, P411
[8]   URINE FREE CORTISOL IN THE HIGH-DOSE DEXAMETHASONE SUPPRESSION TEST FOR THE DIFFERENTIAL-DIAGNOSIS OF THE CUSHING SYNDROME [J].
FLACK, MR ;
OLDFIELD, EH ;
CUTLER, GB ;
ZWEIG, MH ;
MALLEY, JD ;
CHROUSOS, GP ;
LORIAUX, DL ;
NIEMAN, LK .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (03) :211-217
[9]  
HOLDAWAY IM, 1973, NZ J MED, V3, P507
[10]   THE CUSHING SYNDROME - AN UPDATE ON DIAGNOSTIC-TESTS [J].
KAYE, TB ;
CRAPO, L .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :434-444